ESPR Hedge Fund Ownership (Q1 2026)

Esperion Therapeutics Inc Ne (ESPR)

206 + Investors. Track Smart Money conviction in ESPR. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ESPR

Based on 207 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added ESPR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

207 hedge funds hold ESPR right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +12% more funds vs a year ago

fund count last 6Q

+22 new funds entered over the past year (+12% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟡

Slight buying edge — 53% buying

107 buying96 selling

Last quarter: 107 funds bought or added vs 96 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

➡️

Steady new buyers — ~40 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 13 → 50 → 44 → 40. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

55% of holders stayed for 2+ years

■ 55% conviction (2yr+) ■ 26% medium ■ 20% new

113 out of 207 hedge funds have held ESPR for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares +16%, value -14%

Value

-13%

+16%

Last quarter: funds added +16% more shares while total portfolio value only changed -14%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📈

Growing discovery — still being found

25 → 13 → 50 → 44 → 40 new funds/Q

New funds entering each quarter: 13 → 50 → 44 → 40. A growing number of institutions are discovering ESPR each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Veteran-anchored — 63% veterans vs 22% newcomers

■ 63% veterans ■ 16% 1-2yr ■ 22% new

Entry-cohort mix of 218 holders: 137 (63%) are 2+ year veterans, 34 entered 1–2 years ago, and 47 (22%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

✅

Strong quality — 34% AUM from major funds

34% from top-100 AUM funds

43 of 205 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

3.8

out of 10

Low Exit Risk

Exit risk score 3.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	206	201	2.49%
13F Shares	182M	157M	16.01%
Total Value	$500M	$578M	-13.6%
New Positions	39	44	-5
Increased Positions	64	84	-20
Closed Positions	34	32	+2
Reduced Positions	61	34	+27
Total Calls	8	8	-
Total Puts	5	5	-
PUT/CALL Ratio	0.62	0.62	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

206

201

2.49%

13F Shares

182M

157M

16.01%

Total Value

$500M

$578M

-13.6%

New Positions

-5

Increased Positions

-20

Closed Positions

Reduced Positions

+27

Total Calls

Total Puts

PUT/CALL Ratio

0.62

Bullish

Institutional Holders (2026 Q2)

206 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ESPR. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ESPR holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Trium Capital LLP	21.69%	11,158,150	$35.3M
2	Beryl Capital Management LLC	12.65%	4,431,598	$14.0M
3	Transmarket Holdings LP	3.69%	1,590,721	$5.0M
4	PSquared Asset Management AG	3.41%	3,300,000	$10.4M
5	Chicago Capital Management, LLC	2.32%	830,935	$2.6M
6	PenderFund Capital Management Ltd.	1.57%	3,884,508	$12.3M
7	GABELLI & Co INVESTMENT ADVISERS, INC.	1.06%	2,315,900	$7.3M
8	Gardner Lewis Asset Management L P	0.96%	1,365,251	$4.3M
9	Oddo Bhf Asset Management Sas	0.73%	5,000,000	$15.8M
10	Nexpoint Asset Management, L.P.	0.62%	2,955,920	$9.3M
11	Sagefield Capital LP	0.51%	2,190,108	$6.9M
12	Kintayl Capital LP	0.50%	400,000	$1.3M
13	Yakira Capital Management, Inc.	0.50%	550,011	$1.7M
14	TIG Advisors, LLC	0.36%	2,587,840	$8.2M
15	Summit Wealth Group, LLC	0.32%	499,708	$1.6M
16	Alpine Associates Management INC.	0.30%	1,500,000	$4.7M
17	T3 Companies, LLC	0.28%	82,500	$261K
18	AQR Arbitrage LLC	0.27%	6,046,463	$19.1M
19	Harvest Management LLC	0.25%	200,000	$632K
20	Warberg Asset Management LLC	0.21%	374,000	$1.2M
21	Credit Industriel Et Commercial	0.21%	1,044,420	$3.3M
22	Equitec Proprietary Markets, LLC	0.20%	345,800	$1.1M
23	One68 Global Capital, LLC	0.19%	16,514	$90K
24	Equitec Proprietary Markets, LLC	0.19%	335,800	$1.1M
25	Water Island Capital LLC	0.18%	612,774	$1.9M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Esperion Therapeutics Inc Ne (ESPR)

What does the Smart Money Trend signal show for ESPR?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added ESPR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ESPR?

Slight buying edge — 53% buying: Last quarter: 107 funds bought or added vs 96 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ESPR holders?

Strong quality — 34% AUM from major funds: 43 of 205 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ESPR?

55% of holders stayed for 2+ years: 113 out of 207 hedge funds have held ESPR for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Esperion Therapeutics Inc Ne (ESPR)

Smart Money Signals — ESPR

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Steady growth — +12% more funds vs a year ago

Slight buying edge — 53% buying

Steady new buyers — ~40 new funds per quarter

55% of holders stayed for 2+ years

Buying through price weakness — shares +16%, value -14%

Growing discovery — still being found

Veteran-anchored — 63% veterans vs 22% newcomers

Strong quality — 34% AUM from major funds

Institutional Sentiment Summary — ESPR

Hedge Fund Ownership: ESPR

Market Analysis: ESPR

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ESPR

Hedge Fund Positioning: ESPR

Statistics: ESPR

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Esperion Therapeutics Inc Ne (ESPR)

Welcome to 13Foresight!